deltatrials
Completed NA NCT00361920

Cell Biology of Steroid Resistant Asthma

Investigating Biomarkers of Steroid Resistant Asthma

Sponsor: Genentech, Inc.

Conditions Asthma
Interventions prednisone
Updated 6 times since 2017 Last updated: Mar 27, 2017 Started: Aug 31, 2006 Primary completion: Mar 31, 2007 Completion: Mar 31, 2007

This NA trial investigates Asthma and is currently completed. Genentech, Inc. leads this study, which shows 6 recorded versions since 2006 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Apr 2017 · 3 months · monthly snapshotCompleted~Apr 2017 – ~Jun 2018 · 14 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 19 months · monthly snapshotCompleted

Change History

6 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Jan 2021 — Jul 2024 [monthly]

    Completed NA

  4. Jun 2018 — Jan 2021 [monthly]

    Completed NA

  5. Apr 2017 — Jun 2018 [monthly]

    Completed NA

Show 1 earlier version
  1. Jan 2017 — Apr 2017 [monthly]

    Completed NA

    First recorded

Aug 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Genentech, Inc.
  • National Jewish Health
Data source: National Jewish Health

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations